EY CEO: ‘This is the COP to show, not tell, what climate action looks like’
Fortune via Yahoo Finance· 5 hours agoAn obvious solution is for the private sector, with its considerable resources, to undertake...
...Xenon Pharma's Depression Candidate Shows Positive Signals OfEfficacy, Despite Primary Endpoint...
Benzinga· 3 days agoMonday, Xenon Pharmaceuticals Inc (NASDAQ: XENE) reported topline results from the Phase 2...
Why the Major Drop in Veteran Homelessness Offers Hope for Others
Time via Yahoo News· 5 hours agoAnother lesson, Kushel notes, is the efficacy of reaching homeless people “where they are”—at...
Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 hours agoPipeline Updates In October 2023, INCY announced new positive 52-week data from the IIb dose-ranging...
Why Is This Rare Disease-Focused Soligenix Stock Trading Over 200% Today? - Soligenix (NASDAQ:SNGX)
Benzinga· 4 hours agoThe FDA has cleared Soligenix Inc's SNGX Investigational New Drug (IND) application for a Phase 2a clinical trial for SGX945 (dusquetide) for aphthous ulcers in Behçet's disease. Behçet disease ...
Astellas' Fezolinetant Reduces Frequency and Severity of VMS Associated with Menopause in Women...
WAVE 3 Louisville· 22 hours agoAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 24-week results from the Phase 3b DAYLIGHT clinical trial examining the efficacy
Drug discovery startup Pepper Bio hopes to challenge Eroom's law with new funding
TechCrunch· 3 hours agoWhile the world keeps getting better at churning semiconductors, we are still struggling to find new...
XOMAD Sweeps Ad Age 2023 Social Media Campaign of the Year Awards
WMBF News Myrtle Beach· 2 hours agoXOMAD, a marketing, communications and research company that specializes in mobilizing local social media messengers (influencers), won big at this year's Ad Age Healthcare Marketing Impact ...
Jim Jordan subpoenas ex-White House censorship chief Rob Flaherty over ‘constitutionally protected’...
New York Post· 4 hours agoThe lawsuit turned up a large number of documents showing that Flaherty and his team leaned on...
Acadia (ACAD) Begins Alzheimer's Disease Psychosis Study (Revised)
Zacks· 16 hours agoFree Report) announced that it has initiated a mid-stage study to evaluate the safety and efficacy...
Yahoo Web Search
Trending Now
